Vicarious Surgical (NYSE:RBOT) management offered an update on the development timeline of its surgical robot as part of its fourth-quarter earnings. Previous expectations earmarked mid-2024 for first-in-human trials and fiscal 2025 for de novo clearance submission. However, CEO Adam Sachs pushed V1.0’s timeline back in November 2023. The company outlined plans for a build and […]
Wall Street Beat
Stereotaxis submits Magic ablation catheter for U.S., European approval
Stereotaxis (NYSE:STXS) announced that it submitted its Magic ablation catheter for both European and U.S. regulatory approval. The company said its FDA and CE mark submissions follow successful clinical results in an ongoing trial. Last month, Stereotaxis announced the first Magic treatments in the European trial supporting its submissions. According to a news release, the […]
iRhythm proposes $450M offering
iRhythm announced today that it intends to offer $450 million in convertible senior notes. San Francisco–based iRhythm plans to offer the notes — due 2029 — to qualified institutional buyers. It intends to grant initial purchasers a 13-day option to buy up to an additional $67.5 million in notes. The notes will be senior, unsecured […]
FDA submission for 365-day CGM from Senseonics is ‘imminent’
Senseonics (NYSE:SENS) shares dipped after hours on fourth-quarter results that came in ahead of the consensus forecast. The company also reported an “imminent” submission of its latest, longest-lasting continuous glucose monitoring (CGM) technology. Shares of SENS fell 3.5% to 69¢ apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of […]
Masimo stock dips despite Street-beating Q4
Masimo shares fell slightly despite fourth-quarter results that came in ahead of the consensus forecast. Shares of MASI dipped 2.6% at $126.76 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 0.3%. The Irvine, California–based patient monitoring technology developer posted profits of […]
Smith+Nephew sales are up 7% as 12-point plan progresses
Smith+Nephew shares dipped today on fourth-quarter results that included nearly 7% sales growth year-over-year. Shares of SNN fell 2% to $27.97 apiece in late-afternoon trading. The London-based orthopedic giant posted sales of $1.458 million in the quarter. That marked 6.8% growth compared to the same period a year ago. Smith+Nephew says it continues to make […]
iRhythm stock dips on mixed Q4 as guidance ‘may disappoint’ investors
iRhythm Technologies shares took a hit today on third-quarter results that came in mixed compared to the consensus forecast. Shares of IRTC fell 5.5% at $108.75 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained even. The San Francisco-based heart monitoring technology […]
Insulet begins limited rollout of Omnipod 5 with Dexcom G7, grows sales by 38% in Q4
Insulet announced that it began a limited market release of the Omnipod 5 with the Dexcom G7. This marks the latest integration of Dexcom’s next-generation CGM into automated insulin delivery technology. Omnipod 5, Insulet’s newest patch pump offering, previously worked with the G6 in the U.S. It also recently integrated the system with Abbott’s FreeStyle […]
Boston Scientific prices €2B offering to finance Axonics buy
Boston Scientific announced that it priced an offering worth nearly $2.2 billion (€2 billion) in senior notes. American Medical Systems Europe B.V., Boston Scientific’s wholly-owned finance subsidiary, priced the public offering. It includes €750,000,000 aggregate principal amount of 3.375% notes due in 2029 and €1,250,000,000 aggregate principal amount of 3.500% notes due in 2032. Notes […]
Enovis stock rises on Street-beating Q4, return to profit
Enovis shares got a boost today on fourth-quarter results that landed ahead of the consensus forecast. Shares of ENOV rose 7.4% at $64.72 apiece in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.5%. The Wilmington, Delaware-based company — one of the […]
Teleflex dips despite Street-beating Q4
Teleflex shares took a hit today despite fourth-quarter results that came in ahead of the consensus forecast. Shares of TFX fell 4.6% at $239.36 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The Wayne, Pennsylvania-based company posted profits of $31.1 […]